| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | -0.0077 | 0.9 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.9 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.046 | 0.9 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.9 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.9 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.004 | 0.9 |